5 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseNutritional and Metabolic Diseases, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hypertensive disorder, metabolic disease, type 2 diabetes mellitus, vascular disorderRecruitingPhase 32026-09-30NCT07064473
Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed DyslipidemiaDyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, metabolic diseaseActive, not recruitingNot stated2026-09-30NCT04579367
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD EventArterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, vascular disorderActive, not recruitingPhase 32026-08-11NCT07000123
Evaluation of Four New Ready to Drink Oral Nutritional Supplements: Adult ONS TrialNutritional and Metabolic Diseases, nutritional deficiency disease, nutritional disorderActive, not recruitingNot applicable2026-04-14NCT05257980
Elemental 028 Extra Case StudiesDigestive System Diseases, Nutritional and Metabolic Diseases, allergic disease, digestive system disorder, gastroenteritis, immune system disorder, inflammatory bowel disease, intestinal disorder, malabsorption syndrome, metabolic disease, nervous system disorder, neurodegenerative diseaseRecruitingNot applicable2026-02-17NCT06877923